Literature DB >> 26435037

Resistant Hypertension and Susceptible Outcomes: Exploring the Benefits of Aggressive Blood Pressure Control.

Steven M Smith1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26435037      PMCID： PMC8032058          DOI： 10.1111/jch.12677

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  18 in total

1.  Resistant hypertension? Assessment of adherence by toxicological urine analysis.

Authors:  Oliver Jung; Janis L Gechter; Cora Wunder; Alexander Paulke; Christine Bartel; Helmut Geiger; Stefan W Toennes
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

2.  Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Paul Muntner; Barry R Davis; William C Cushman; Sripal Bangalore; David A Calhoun; Sara L Pressel; Henry R Black; John B Kostis; Jeffrey L Probstfield; Paul K Whelton; Mahboob Rahman
Journal:  Hypertension       Date:  2014-08-04       Impact factor: 10.190

3.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

4.  Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.

Authors:  Dharam J Kumbhani; P Gabriel Steg; Christopher P Cannon; Kim A Eagle; Sidney C Smith; Kevin Crowley; Shinya Goto; E Magnus Ohman; George L Bakris; Todd S Perlstein; Scott Kinlay; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2012-11-09       Impact factor: 29.983

5.  Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension.

Authors:  Stephanie Brinker; Ambarish Pandey; Colby Ayers; Angela Price; Prafull Raheja; Debbie Arbique; Sandeep R Das; Ethan A Halm; Norman M Kaplan; Wanpen Vongpatanasin
Journal:  J Am Coll Cardiol       Date:  2013-12-04       Impact factor: 24.094

6.  Health-related quality of life in persons with apparent treatment-resistant hypertension on at least four antihypertensives.

Authors:  N W Carris; V Ghushchyan; A M Libby; S M Smith
Journal:  J Hum Hypertens       Date:  2015-06-18       Impact factor: 3.012

7.  Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.

Authors:  Sripal Bangalore; Rana Fayyad; Rachel Laskey; David A Demicco; Prakash Deedwania; John B Kostis; Franz H Messerli
Journal:  Am J Med       Date:  2013-11-07       Impact factor: 4.965

8.  Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.

Authors:  Steven M Smith; Yan Gong; Eileen Handberg; Franz H Messerli; George L Bakris; Ali Ahmed; Anthony A Bavry; Carl J Pepine; Rhonda M Cooper-Dehoff
Journal:  J Hypertens       Date:  2014-03       Impact factor: 4.844

9.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

10.  Improvement in All-Cause Mortality With Blood Pressure Control in a Group of US Veterans With Drug-Resistant Hypertension.

Authors:  Omid Fatemi; Cristobal Goa; Charles Faselis; Peter Kokkinos; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-06       Impact factor: 3.738
View more
  1 in total

1.  Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.

Authors:  Steven M Smith; Nicholas W Carris; Eric Dietrich; John G Gums; Liz Uribe; Christopher S Coffey; Tyler H Gums; Barry L Carter
Journal:  J Am Soc Hypertens       Date:  2016-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.